Other
Drug Facts
The following Structured Product Label (SPL) was submitted to the FDA by Insight Pharmaceuticals for the product Nostrilla (NDC 63736-072). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding other, otc - active ingredient, uses, otc - ask doctor, otc - when using, otc - stop use, otc - pregnancy or breast feeding, otc - keep out of reach of children, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Drug Facts
| Active Ingredient (per spray) | Purpose |
| oxymetazoline hydrochloride 0.05% . . . . . . . . . . . . Nasal decongestant | |
for temporary relief of nasal congestion
For nasal use only. Ask a doctor before use if you have
When using this product
Stop use and ask a doctor if symptoms persist
The use of this container by more than one person may spread infection
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
do not exceed 2 doses in any 24 hour period
| adults and children 6 to under 12 years of age (with adult supervision) | 2 or 3 sprays in each nostril not more often than every 10 to 12 hours. |
| children under 6 years of age | ask a doctor |
benzalkonium chloride solution, camphor, carbomer 934P, carboxymethylcellulose sodium, edetate disodium, eucalyptol, glycine, hyaluronic acid sodium, menthol, polyethylene glycol, propylene glycol, sodium hydroxide, water.
* Please review the disclaimer below.